Consulting Wallah › Market Intelligence › Egypt medical devices market
Market Intelligence · Medical devices

Egypt medical devices market: size, growth and outlook 2026–2032

Unified public procurement (UPA) and localisation incentives reshape a large import-dependent market. Sized from published research with a GCC and India lens, for buyers, suppliers and investors.

Published 03 Nov 2026Updated 03 Nov 2026Forecast 2026–2032Base year 2025Report code CW-MI-EGY
2025 market (CW estimate)USD 1.8 bnsingle published source
2032 (CW estimate)USD 2.9 bncentral case, ~7% CAGR

Executive summary

Unified public procurement (UPA) and localisation incentives reshape a large import-dependent market. Published estimates normalised to 2025 range from — to —; the Consulting Wallah central estimate is USD 1.8 bn, growing at about 7% a year to USD 2.9 bn by 2032. Scope differences between publishers explain most of the spread — the comparison table below states each one.

Growth is driven by population approaching 120 million with rising chronic disease (diabetes, CVD, cancer); universal Health Insurance rollout (law 2018; phased from Port Said to all 27 governorates over a decade); public health allocation EGP 397 bn (USD 7.8 bn) FY2023/24, +30% y/y; 23 new hospitals under construction.

Context that matters for buyers and suppliers: Egypt imports approximately 90% of its medical devices. EDA registration for Class II/III devices can take 12-24 months without prior preparation; local registration holder required. Egypt's pharma + medical supplies exports: USD 950 mn (2023), USD 1.07 bn (2024), USD 1.3 bn (2025), ~21% annual growth. EDA Central Administration for Medical Devices is simplifying registration with updated guidelines and templates.

Market size and forecast

The chart shows the Consulting Wallah central estimate: published figures normalised to 2025, median taken, and projected at the median published growth rate. The published range for 2025 is —–—; differences are mostly scope.

3.22.41.60.80.01.5720231.6820241.820251.9320262.0620272.2120282.3620292.5220302.720312.892032USD billion · dark = reported/historical · orange = estimate · light orange = forecast
Egypt medical devices market, USD bn. Dark bars reconstructed from the central estimate; 2025 onward Consulting Wallah estimate. Sources listed below.

How published estimates compare

Publisher (date)Base valueForecastCAGR
Nexdigm (2026-04) — country / medical devices; blog gives forecast only, no baseNone ()USD 3.5 bn ('by next decade') ()—
Market Research Future (2025-09 (updated 2026-09)) — labelled Egypt but page mixes MEA regional shares (GCC 12.5%USD 28.59 bn (2025: USD 30.6 bn) (2024)USD 56.4 bn (2035)6.37% (2025-2035)
US International Trade Administration (Country Commercial Guide) (2025-11) — country / public health budget, not device market sizeEGP 397 bn (USD 7.8 bn) public health allocation FY2023/24 (+30% y/y) (2024)— ()—
Egyptian Drug Authority (via Export Council for Medical Industries) (2026-05) — country / combined pharma + medical supplies exports, not maUSD 1.3 bn exports of pharmaceuticals + medical supplies (2024: USD 1.07 bn; 2023: USD 0.95 bn) (2025)— ()~21% export growth
Consulting Wallah central estimateUSD 1.8 bn (2025)USD 2.9 bn (2032)~7%

Source: Publisher pages as listed under Sources; CW estimate as described in Method.

Scope and definitions

Included: capital equipment, implants, single-use consumables and IVD instruments and reagents. Excluded: pharmaceuticals, hospital IT, commodity PPE where reported separately. Publishers differ on whether IVD and consumables are included.

Segment and sub-market figures

AxisSegmentFigureNote
ApplicationDiagnostic deviceslargest
ApplicationTherapeutic devicesfastest-growing
End useHospitalslargest
End useHome carefastest-growing
Device typeElectro-medicallargest
Device typeImagingfastest-growing

Source: As listed under Sources.

Country and regional figures

Country / regionFigureYearSource
Egypt import dependence for medical devices~90%2026Taevas Global
Egypt total health expenditureUSD 20.71 bn (government share 37.2%)2021Market Research Future
Pharma + medical supplies exports to AfricaUSD 324 mn (2024: USD 299 mn)2025EDA
New hospitals under construction23 (77% of projects nearing completion)2025US ITA

Source: Sources as named; see Sources and method.

Key facts and context

  • Egypt imports approximately 90% of its medical devices (Taevas Global)
  • EDA registration for Class II/III devices can take 12-24 months without prior preparation; local registration holder required (Taevas Global)
  • Egypt's pharma + medical supplies exports: USD 950 mn (2023), USD 1.07 bn (2024), USD 1.3 bn (2025), ~21% annual growth (EDA)
  • EDA Central Administration for Medical Devices is simplifying registration with updated guidelines and templates (EDA)
  • Public health allocation EGP 397 bn (USD 7.8 bn) in FY2023/24, a 30% increase (US ITA)
  • State-owned El Gomhoureya Company dominates medical equipment imports and is being restructured (US ITA)
  • Universal Health Insurance Law (2018) rolling out in phases from Port Said to all 27 governorates; UHIA manages standardised tenders (Taevas Global)

GCC and India outlook

Where the GCC and India sit

  • Egypt import dependence for medical devices: ~90% (2026) — Taevas Global
  • Egypt total health expenditure: USD 20.71 bn (government share 37.2%) (2021) — Market Research Future
  • Pharma + medical supplies exports to Africa: USD 324 mn (2024: USD 299 mn) (2025) — EDA
  • New hospitals under construction: 23 (77% of projects nearing completion) (2025) — US ITA

Consulting Wallah works this market from both sides: hospital groups in the UAE, Saudi Arabia, India and Bangladesh as buyers, and manufacturers in India, China, Singapore, Malaysia and the US as suppliers through the Network. Our observation is that registration status, in-country stock and structured quotations decide access in the GCC, while price and distributor reach decide it in India. CW observation

Opportunities we see: localisation push: EDA/Export Council roadmap to localise medical industries and raise exports (USD 1.3 bn pharma + supplies exports 2025, +21%); africa export hub ambitions (exports to Africa USD 324 mn in 2025); centralised UPA/UHIA tenders offering volume for pre-qualified suppliers.

Market dynamics

Growth drivers

  • Population approaching 120 million with rising chronic disease (diabetes, CVD, cancer)
  • Universal Health Insurance rollout (law 2018; phased from Port Said to all 27 governorates over a decade)
  • Public health allocation EGP 397 bn (USD 7.8 bn) FY2023/24, +30% y/y; 23 new hospitals under construction
  • Government incentives for local manufacturing (tax breaks, industrial zone incentives, import substitution, JVs)
  • Adoption of telemedicine, AI diagnostics and robotic surgery

Restraints

  • ~90% import dependence raising hospital costs; FX constraints
  • Complex, slow registration (EDA Class II/III can take 12-24 months without prior preparation)
  • Limited domestic manufacturing capacity
  • FY2025/26 public health allocation below constitutional minimum (ITA)

Opportunities

  • Localisation push: EDA/Export Council roadmap to localise medical industries and raise exports (USD 1.3 bn pharma + supplies exports 2025, +21%)
  • Africa export hub ambitions (exports to Africa USD 324 mn in 2025)
  • Centralised UPA/UHIA tenders offering volume for pre-qualified suppliers
  • Local assembly and JV partnerships with international manufacturers
  • Home care and imaging as fastest-growing segments

Challenges

  • EDA requires a locally appointed registration holder and full risk-class technical dossier
  • Bureaucratic red tape persists despite registration improvements (ITA)
  • State-owned El Gomhoureya dominates imports and is under restructuring
  • Currency volatility and import financing

Recent developments

DateDevelopmentSource
2026-05EDA joined Export Council for Medical Industries workshop on medical device exports and industry localisation; UPA representedEDA
2025-11US ITA updated Egypt Medical Equipment & Supplies commercial guide: 23 hospitals under construction, El Gomhoureya restructuringUS ITA
2025-10Philips unveiled portable diagnostic devices for low-resource settingsMarket Research Future
2025-11Siemens Healthineers launched telehealth platform for remote patient monitoringMarket Research Future

Source: Company and press announcements as named.

Competitive landscape

Key companies named across the sources; local distributors and implementation partners matter as much as the brand in the GCC and India.

Siemens HealthineersMedtronicPhilipsGE HealthCareJohnson & JohnsonBaxterStrykerBoston ScientificAbbottCardinal HealthRoche DiagnosticsEl Gomhoureya Company (state-owned distributor)Life Care Medical Devices Company (local)Unified Procurement Authority (UPA, buyer)Universal Health Insurance Authority (UHIA, buyer)

What it means for you

  • Manufacturers and exporters: registration first, local partner second, tender readiness third — see what GCC buyers need.
  • Hospital leaders: total cost of ownership (service, consumables, software) outweighs purchase price; tender the bundle.
  • Investors: local assembly and distribution platforms backed by procurement preference.

Frequently asked questions

How big is the Egypt medical devices market?

Published estimates normalised to 2025 range from — to —. Consulting Wallah’s central estimate is USD 1.8 bn in 2025, rising to about USD 2.9 bn by 2032.

What is the growth rate?

See the sources listed on this page.

Which companies lead?

Siemens Healthineers, Medtronic, Philips, GE HealthCare, Johnson & Johnson, Baxter, Stryker, Boston Scientific among others.

Is the full report free?

The summary on this page is free to read and share with attribution. The full report is free for hospital leaders and registered Consulting Wallah Network members, and priced on request for others.

Sources and method

  1. Nexdigm, Egypt Medical Devices Industry blog — nexdigm.com
  2. Market Research Future, Egypt Medical Device Market Research Report 2035 — marketresearchfuture.com
  3. US International Trade Administration, Egypt Country Commercial Guide - Medical Equipment & Supplies — trade.gov
  4. Taevas Global, Egypt Medical Devices Market Intelligence — taevasglobal.com
  5. Egyptian Drug Authority, EDA participates in workshop to enhance medical device exports and localize industry — edaegypt.gov.eg
  6. Ken Research, Egypt Medical Devices and Equipment Market (paywalled) — kenresearch.com
  7. Consulting Wallah Network — anonymised observations from procurement and business-setup work with hospital groups and suppliers in the UAE, India and Bangladesh (2024–26), used for the GCC/India outlook and the “what it means” section.
  8. Method. Each published figure is normalised to a 2025 base using its own CAGR; the Consulting Wallah central estimate is the median of the normalised figures (or the stated scope where noted) projected at the median CAGR to 2032. Country figures are quoted as published; where we add a CW estimate it is labelled.

Request the full report

The full report (PDF, 40 pages) adds the GCC and India deep-dives, hospital-level benchmarks from the Consulting Wallah Network and the full source tables. Free for hospital leaders and registered network members; otherwise priced on request.

How to read these figures. Published market-size estimates for this market vary widely because publishers define scope differently (software only vs software + services + logistics). Where we show a Consulting Wallah estimate we state the range of published figures it is triangulated from and our scope. Figures marked as reported are quoted from the named source. Nothing here is investment advice.

Want this applied to your hospital or group?Free executive assessment — spend snapshot, benchmark and opportunity brief. Four slots a month.
Book the assessment